July 8, 2020 / 1:05 PM / in a month

BRIEF-Cormedix Inc. Reports Submission Of Defencath™ New Drug Application

July 8 (Reuters) - CorMedix Inc:

* CORMEDIX INC. REPORTS SUBMISSION OF DEFENCATH™ NEW DRUG APPLICATION

* CORMEDIX INC - REQUESTED PRIORITY REVIEW OF NDA, BASED ON FAST TRACK AND QUALIFIED INFECTIOUS DISEASE PRODUCT DESIGNATIONS GRANTED BY FDA TO DEFENCATH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below